Protein profiles of peripheral blood mononuclear cells as a candidate biomarker for Behçet's disease

Clinical and Experimental Rheumatology

Volumn 32, Issue , 2014, Pages S9-S19

  Yoshioka, Takuya ^a,b   Kurokawa, Manae S ^a   Sato, Toshiyuki ^a   Nagai, Kouhei ^a   Iizuka, Nobuko ^a   Arito, Mitsumi ^a   Takakuwa, Yukiko ^b   Nakano, Hiromasa ^b   Ooka, Seido ^b   Suematsu, Naoya ^a   Okamoto, Kazuki ^a   Yudoh, Kazuo ^b   Nakamura, Hiroshi ^c   Suzuki, Noboru ^b   Ozaki, Shoichi ^b   Kato, Tomohiro ^a  

^a ST MARIANNA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Beh et's disease; Biomarkers; Mass spectrometry; Peripheral blood mononuclear cells; Proteomics

Indexed keywords

BETA ACTIN; BIOLOGICAL MARKER; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 4; SYNTHETASE; THREONINE SYNTHASE LIKE 2; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; BEHCET DISEASE; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOSKELETON; FEMALE; HUMAN; HUMAN CELL; MALE; MASS SPECTROMETRY; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN PROCESSING; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION; TWO DIMENSIONAL GEL ELECTROPHORESIS; ARTHRITIS, RHEUMATOID; BEHCET SYNDROME; DIFFERENTIAL DIAGNOSIS; IMMUNOLOGY; METABOLISM; MONONUCLEAR CELL; PROCEDURES; PROTEOMICS; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

ADOLESCENT; ADULT; AGED; ARTHRITIS, RHEUMATOID; BEHCET SYNDROME; BIOLOGICAL MARKERS; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MASS SPECTROMETRY; MIDDLE AGED; PROTEOMICS; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

EID: 84907512419     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. SAKANE T, TAKENO M, SUZUKI N, INABA G: Behçet's disease. N Engl J Med 1999; 341: 1284-91.
2. KUROKAWA MS, SUZUKI N: Behçet's disease. Clin Exp Med 2004; 4: 10-20.
3. EVEREKLIOGLU C: Ocular Behçet disease: current therapeutic approaches. Curr Opin Ophthalmol 2011; 22: 508-16.
4. PINETON DE CHAMBRUN M, WECHSLER B, GERI G, CACOUB P, SAADOUN D: New insights into the pathogenesis of Behçet's disease. Autoimmun Rev 2012; 11: 687-98.
5. ERGUN T, INCE U, EKSIOGLU-DEMIRALP E et al.: HSP 60 expression in mucocutaneous lesions of Behçet's disease. J Am Acad Dermatol 2001; 45: 904-9.
6. PERVIN K, CHILDERSTONE A, SHINNICK T et al.: T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease. J Immunol 1993; 151: 2273-82.
7. DIRESKENELI H, SARUHAN-DIRESKENELI G: The role of heat shock proteins in Behçet's disease. Clin Exp Rheumatol 2003; 21: S44-8.
8. IMAMURA Y, KUROKAWA MS, YOSHIKAWA H et al.: Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behçet's disease. Clin Exp Immunol 2005; 139: 371-8.
9. NARA K, KUROKAWA MS, CHIBA S et al.: Involvement of innate immunity in the pathogenesis of intestinal Behçet's disease. Clin Exp Immunol 2008; 152: 245-51.
10. CHINO E, STANFORD M, HASAN A et al.: HSP-derived peptides inducing uveitis and IgG and IgA antibodies. Exp Eye Res 1998; 67: 719-27.
11. DE MENTHON M, LAVALLEY MP, MALDINI C, GUILLEVIN L, MAHR A: HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum 2009; 61: 1287-96.
12. REMMERS EF, COSAN F, KIRINO Y et al.: Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat Genet 2010; 42: 698-702.
13. MIZUKI N, MEGURO A, OTA M et al.: Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat Genet 2010; 42: 703-6.
14. WANG X, ZHANG MF, XIE J, LI ZL, WANG P: Behçet's disease with active uveitis: detection of serum protein biomarkers using MALDI-TOF-MS. Anat Rec 2012; 295: 1168-73.
15. MAO L, DONG H, YANG P et al.: MALDI-TOF/TOF-MS reveals elevated serum haptoglobin and amyloid A in Behçet's disease. J Proteome Res 2008; 7: 4500-7.
16. LEE KH, CHUNG HS, KIM HS et al.: Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease. Arthritis Rheum 2003; 48: 2025-35.
17. OKUNUKI Y, USUI Y, TAKEUCHI M et al.: Proteomic surveillance of autoimmunity in Behçet's disease with uveitis: selenium binding protein is a novel autoantigen in Behçet's disease. Exp Eye Res 2007; 84: 823-31.
18. OKUNUKI Y, USUI Y, KEZUKA T et al.: Proteomic surveillance of retinal autoantigens in endogenous uveitis: implication of esterase D and brain-type creatine kinase as novel autoantigens. Mol Vis 2008; 14: 1094-104.
19. OOKA S, NAKANO H, MATSUDA T et al.: Proteomic surveillance of autoantigens in patients with Behçet's disease by a proteomic approach. Microbiol Immunol 2010; 54: 354-61.
20. HATSUGAI M, KUROKAWA MS, KOURO T et al.: Protein profiles of peripheral blood mononuclear cells are useful for differential diagnosis of ulcerative colitis and Crohn's disease. J Gastroenterol 2010; 45: 488-500.
21. Criteria for diagnosis of Behçet's disease: International Study Group for Behçet's Disease. Lancet 1990; 335: 1078-80.
22. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
23. FUJISAWA H, OHTANI-KANEKO R, NAIKI M et al.: Involvement of post-translational modification of neuronal plasticity-related proteins in hyperalgesia revealed by a proteomic analysis. Proteomics 2008; 8: 1706-19.
24. NEISCH AL, FEHON RG: Ezrin, Radixin and Moesin: key regulators of membrane-cortex interactions and signaling. Curr Opin Cell Biol 2011; 23: 377-82.
25. GU MX, YORK JD, WARSHAWSKY I, MAJERUS PW: Identification, cloning, and expression of a cytosolic megakaryocyte protein-tyrosine-phosphatase with sequence homology to cytoskeletal protein 4.1. Proc Natl Acad Sci U S A 1991; 88: 5867-71.
26. BAULER TJ, HENDRIKS WJ, KING PD: The FERM and PDZ domain-containing protein tyrosine phosphatases, PTPN4 and PTPN3, are both dispensable for T cell receptor signal transduction. PLoS One 2008; 3: e4014.
27. SHAV-TAL Y, ZIPORI D: PSF and p54(nrb)/NonO-multi-functional nuclear proteins. FEBS Lett 2002; 531: 109-14.
28. DREYFUSS G, MATUNIS MJ, PINOL-ROMA S et al.: hnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem 1993; 62: 289-321.
29. WEIGHAEDT F, BIAMONTI G, RIVA S: The roles of heterogeneous nuclear ribonucleoproteins (hnRNP) in RNA metabolism. Bioessays 1996; 18: 747-56.
30. OU JH, YEN TS, WANG YF, KAM WK, RUTTER WJ: Cloning and characterization of a human ribosomal protein gene with enhanced expression in fetal and neoplastic cells. Nucleic Acids Res 1987; 15: 8919-34.
31. MESKAUSKAS A, DINMAN JD: Ribosomal protein L3: gatekeeper to the A site. Mol Cell 2007;25: 877-88.
32. JANJI B, GIGANTI A, DE CORTE V et al.: Phosphorylation on Ser5 increases the F-actin-binding activity of L-plastin and promotes its targeting to sites of actin assembly in cells. J Cell Sci 2006; 119: 1947-60.
33. WABNITZ GH, KOCHER T, LOHNEIS P et al.: Costimulation induced phosphorylation of L-plastin facilitates surface transport of the T cell activation molecules CD69 and CD25. Eur J Immunol 2007; 37: 649-62.
34. RIFAS L, WEITZMANN MN: A novel T cell cytokine, secreted osteoclastogenic factor of activated T cells, induces osteoclast formation in a RANKL-independent manner. Arthritis Rheum 2009; 60: 3324-35.
35. ZUNIGA E, RIPPEN M, ALEXANDER C, SCHILLING TF, CRUMP JG: Gremlin 2 regulates distinct roles of BMP and Endothelin 1 signaling in dorsoventral patterning of the facial skeleton. Development 2011; 138: 5147-56.
36. TEREBIZNIK MR, VAZQUEZ CL, TORBICKI K et al.: Helicobacter pylori VacA toxin promotes bacterial intracellular survival in gastric epithelial cells. Infect Immun 2006; 74: 6599-614.